Company profile
Pin Therapeutics company profile
Pin Therapeutics is founded in Feb 2017, fast growing stage with member composition of 25% in USA and 75% in Korea. Drug discovery leaderships are from global pharma and biotech companies along with talented scientists both in Korea and USA. * Active Focus - PinE3: E3 ligase screening cascade for identifying novel warheads - PinGLUE: Assay cascade for molecular glue degrader screening * Programs - Selective Molecular Glue Degrader (CK1α) - Molecular Glue Degrader Programs (5-6 Undisclosed) - PROTAC Program (1 Undisclosed)
Business identity
- Contact email
- [email protected]
- Phone number
- +82 392-87-00875
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2017-02-01, Month
Headquarters
- Headquarters
- Seongnam-si, Gyeonggi-do, South Korea
- Country code
- KR
- Continent
- Asia